je.st
news
ASCO 2015: NDA coming soon as Clovis unveils data in ovarian, NSCLC
2015-05-31 23:38:49| Logistics - Topix.net
Clovis Oncology Inc. took a big step ahead in preparations for filing its new drug application for the experimental non-small cell lung cancer therapy, rociletinib, showcasing data from an ongoing phase II study testing the drug in a group of heavily pre-treated patients, most of whom had developed resistance to current treatments. The company, which plans to use the data as part of a rolling submission to the FDA slated to begin in June, provided the update at the American Society of Clinical Oncology annual meeting.
Tags: data
coming
nda
unveils
Category:Transportation and Logistics
Latest from this category |
All news |
||||||||||||||||||
|
|||||||||||||||||||